期刊文献+

YAP蛋白在不同恶性程度的胃癌组织中的表达及其死亡率的影响 被引量:7

The YAP expression levels and their influence on mortality of different clinical stages gastric carcinoma patients
原文传递
导出
摘要 目的探讨YAP蛋白在临床不同分期、恶性程度不同的胃癌组织中的表达差异,及其同胃癌死亡率的影响。方法选择2013年8月至2015年1月湖北省江汉大学附属医院胃癌临床Ⅰ期组织块17例、Ⅱ期胃癌组织35例、Ⅲ期胃癌组织42例和Ⅳ期31例,以及相应的癌旁组织作为对照,采用免疫组化(IHC)和Western blot方法分别检测YAP蛋白表达水平,分析其与胃癌死亡率的相关性。结果胃癌组织中YAP表达水平显著高于癌旁组织(P=0.002 1),差异有统计学意义(P<0.05)。YAP在不同分期的胃癌病人中表达也具有差异性,且恶性程度越高的胃癌组织中,YAP表达量越多;YAP表达水平与临床Ⅲ期(P=0.020)和临床Ⅳ期(P=0.007)患者死亡率有显著性相关,YAP高表达的胃癌病人生存率显著低于YAP低表达的胃癌病人。结论胃癌的恶性程度与YAP的表达呈正相关,异常高表达YAP的胃癌病人一般伴随不良预后和高死亡率。 Objective To explore YAP(Yes associated protein) expression levels at different clinical stages tissues of gastric cancers,and itsassociation with the mortality of patients. Methods 17 cases of clinical stageⅠ, 35 cases of stageⅡ, 42 cases of stage Ⅲ and 31 cases of stage Ⅳof gastric cancer were selected for the study. YAP protein expression level was detected by immunohistochemistry(IHC) and Western blot. Results YAP expression in gastric cancer tissue were significantly higher than that of normal tissue adjacent to carcinoma(P=0.002 1).The higher the malignant degree of gastric cancer tissues, the higher was the YAP expressing level. YAP protein expression level and clinical Ⅲ stage(P=0.020)and clinical Ⅳ stage(P=0.007) mortality in patients with significant correlation, the difference was statistically significant(P〈0.05); The survival rate of gastric cancer patient with YAP high expression was significantly lower than that with YAP negative. Conclusion The malignant degree of gastric cancer was positively correlated with the expression level of YAP,abnormally high expression of YAP in gastric cancer patients usually associated with poor prognosis and with high mortality.
作者 贾业贵 许浪
出处 《热带医学杂志》 CAS 2016年第9期1174-1176,1180,F0004,共5页 Journal of Tropical Medicine
关键词 胃癌 死亡率 YAP Hippo信号通路 Gastric cancer Mortality YAP Hippo signaling pathway
  • 相关文献

参考文献4

二级参考文献37

  • 1徐青,马利林,陈瑞新,王志伟,陈钟,陈玉泉.肝细胞肝癌患者围手术期免疫状况检测的临床意义[J].江苏医药,2005,31(12):886-888. 被引量:10
  • 2李明,朱传武,钱峰,王海燕,诸葛洪祥.慢性乙型肝炎患者外周血单个核细胞穿孔素表达与干扰素抗病毒疗效的关系[J].中华肝脏病杂志,2006,14(10):729-731. 被引量:8
  • 3Jee SH, Shen SC, Chiu HC, et al. Over-expression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency [ J ]. Oncogene, 2006,20 (2) : 198- 208. 被引量:1
  • 4Kobayashi H, Lin PC. Molecular characterization of IL-32 in human endothelial cells [J]. Cytokine, 2009,46 (3) : 351-358. 被引量:1
  • 5Carter KL, Cahir-McFarland E, Kieff E. Epstein-barr virusinduced changes in B-lymphocyte gene expression [J]. J Virol, 2002,76 (20) : 10427 - 10436. 被引量:1
  • 6Frau M, Biasi F, Feo F, et al. Prognostic markers and putative therapeutic targets for hepatocellular carcinoma [ J]. Mol Aspects Med, 2010, 31(2) : 179 -193. 被引量:1
  • 7Akhoondi S, Sun D, van der Lehr N, et al. FBXW7/hCDC4 is a general tumor suppressor in human cancer[ J]. Cancer Res, 2007, 67 (19) : 9006-9012. 被引量:1
  • 8Mao JH, Perez-Losada J, Wu D, et al. Fbxw7/Cde4 is a p53-dependent, haploinsufficient tumour suppressor gene[ J]. Nature, 2004, 432 (9) : 775 - 779. 被引量:1
  • 9Liu YH, Tong ZW, Li T, et al. Hepatitis B virus X protein stabilizes amplified in breast cancer 1 protein and cooperates with it to promote human hepatocellular carcinoma cell invasiveness [ J ]. Hepatology, 2012, 56(3) : 1015 -1024. 被引量:1
  • 10Chen MC, Chen CH, Chuang HC, et al. A novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase Ⅱα degradation in hepatocellular carcinoma cells[ J]. Hepatology, 2011,53 ( 1 ) : 148 -159. 被引量:1

共引文献83

同被引文献58

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部